| P2093 | author name string | J V Leonard | |
| | A A Morris | |
| P2860 | cites work | Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency | Q24308632 |
| | A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. The Dichloroacetate-Lactic Acidosis Study Group | Q28202643 |
| | Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy | Q28360128 |
| | 31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle. | Q29039246 |
| | Hydroperoxide metabolism in mammalian organs | Q29614205 |
| | Dilated cardiomyopathy due to type II X-linked 3-methylglutaconic aciduria: successful treatment with pantothenic acid | Q33614196 |
| | Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? | Q35254212 |
| | Leigh syndrome, a mitochondrial encephalo(myo)pathy. A review of the literature | Q36447731 |
| | Gene therapy for mitochondrial DNA defects: is it possible? | Q40480191 |
| | Biological markers of oxidative stress in mitochondrial myopathies with progressive external ophthalmoplegia | Q41132308 |
| | Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of 31P NMR. | Q41583686 |
| | Coenzyme Q in serum and muscle of 5 patients with Kearns-Sayre syndrome and 12 patients with ophthalmoplegia plus | Q42197214 |
| | Variable clinical presentation in patients with defective E1 component of pyruvate dehydrogenase complex | Q42512207 |
| | MELAS syndrome with mitochondrial tRNA(Leu)(UUR) mutation: correlation of clinical state, nerve conduction, and muscle 31P magnetic resonance spectroscopy during treatment with nicotinamide and riboflavin | Q44244041 |
| | Therapeutic effect of sodium dichloroacetate on visual and auditory hallucinations in a patient with MELAS. | Q44946882 |
| | Leigh syndrome associated with a deficiency of the pyruvate dehydrogenase complex: results of treatment with a ketogenic diet | Q45237461 |
| | Metabolic disorders of embryogenesis | Q46364985 |
| | Assessment and therapy monitoring of Leigh disease by MRI and proton spectroscopy | Q48566621 |
| | A mitochondrial myopathy in an infant with lactic acidosis. | Q52241170 |
| | Ubidecarenone in the treatment of mitochondrial myopathies: a multi-center double-blind trial. | Q54088093 |
| | Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders | Q57043166 |
| | Coenzyme Q10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease | Q57043469 |
| | Vitamin-responsive complex I deficiency in a myopathic patient with increased activity of the terminal respiratory chain and lactic acidosis | Q57189960 |
| | Pyruvate dehydrogenase deficiency: Molecular basis for intrafamilial heterogeneity | Q57655520 |
| | 31P NMR examination of two patients with NADH-CoQ reductase deficiency | Q59058195 |
| | Beneficial effect of sodium dichloroacetate in muscle cytochrome C oxidase deficiency | Q60746562 |
| | El Pyruvate Dehydrogenase Deficiency in a Child with Motor Neuropathy | Q63531761 |
| | Thiamine Responsive Pyruvate Dehydrogenase Deficiency | Q67479869 |
| | Ketonic diet in the management of pyruvate dehydrogenase deficiency | Q67527787 |
| | Vitamin-responsive pyruvate dehydrogenase deficiency in a young girl with external ophthalmoplegia, myopathy and lactic acidosis | Q67560157 |
| | Marked reduction in CSF lactate and pyruvate levels after CoQ therapy in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) | Q67967357 |
| | 31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies | Q68150271 |
| | Long-term coenzyme Q10 therapy for a mitochondrial encephalomyopathy with cytochrome c oxidase deficiency: a 31P NMR study | Q69335917 |
| | Mitochondrial encephalomyopathy (MELAS): pathological study and successful therapy with coenzyme Q10 and idebenone | Q69640505 |
| | Mitochondrial myopathy and cardiomyopathy in siblings | Q69647475 |
| | Benign mitochondrial myopathy with deficiency of NADH-CoQ reductase and cytochrome c oxidase | Q70162893 |
| | Benign infantile mitochondrial myopathy due to reversible cytochrome c oxidase deficiency | Q70167731 |
| | Lipoamide dehydrogenase deficiency with primary lactic acidosis: favorable response to treatment with oral lipoic acid | Q70459531 |
| | Molecular analysis of abnormal pyruvate dehydrogenase in a patient with thiamine-responsive congenital lactic acidemia | Q72378327 |
| | NADH-CoQ reductase deficient myopathy: successful treatment with riboflavin | Q72560397 |
| | Treatment of complex I deficiency with riboflavin | Q72576684 |
| | Transient improvement of congenital lactic acidosis in a male infant with pyruvate decarboxylase deficiency treated with dichloroacetate | Q72888817 |
| | Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy | Q93604788 |
| P433 | issue | 4 | |
| P921 | main subject | congenital disorder | Q727096 |
| P304 | page(s) | 573-580 | |
| P577 | publication date | 1996-01-01 | |
| P1433 | published in | Journal of Inherited Metabolic Disease | Q6295359 |
| P1476 | title | The treatment of congenital lactic acidoses | |
| P478 | volume | 19 | |